PMC:7219429 / 2894-3085
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T16 | 169-177 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 48-49 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T33 | 89-94 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2], a |
T34 | 151-152 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T48 | 70-81 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 0-191 | Sentence | denotes | Following initial reports from China indicating a potential effect of chloroquine (CLQ) [2], a preliminary clinical trial was implemented in France on a small cohort of COVID-19 patients [3]. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
114 | 178-186 | Species | denotes | patients | Tax:9606 |
123 | 70-81 | Chemical | denotes | chloroquine | MESH:D002738 |
124 | 83-86 | Chemical | denotes | CLQ | MESH:D002738 |
132 | 169-177 | Disease | denotes | COVID-19 | MESH:C000657245 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32405156-32074550-48150995 | 89-90 | 32074550 | denotes | 2 |
T20596 | 89-90 | 32074550 | denotes | 2 |